Back to search

Article

The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular Disease

2024-04-22

Abstract excerpt

<h4>Introduction</h4> In peripheral arterial disease (PAD) anti-angiogenic VEGF-A 165 b isoform overexpression in monocytes contributes to impaired collateralisation. Serine-arginine protein-kinase-1 (SRPK1) regulates VEGF splicing. To determine whether SRPK1 controlled monocytic VEGF, impairing collateralisation, we investigated SRPK1 inhibition and monocyte-specific knockout in mouse models of and in human mon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb000948-da86-5f64-8bb7-94df3cb01933
DOI
10.1101/2024.04.17.589996
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The splicing factor kinase SRPK1 is a therapeutic target for Peripheral Vascular DiseaseDOI 10.1101/2024.04.17.589996
Select a neighboring publication to make it the new centre.